DAVENPORT & Co LLC boosted its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 10.8% in the first quarter, HoldingsChannel reports. The firm owned 549,541 shares of the real estate investment trust’s stock after buying an additional 53,498 shares during the period. DAVENPORT & Co LLC’s holdings in Healthpeak Properties were worth $11,112,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds also recently added to or reduced their stakes in DOC. Mizuho Bank Ltd. purchased a new position in shares of Healthpeak Properties during the 4th quarter valued at about $28,000. Harvest Fund Management Co. Ltd acquired a new stake in Healthpeak Properties during the fourth quarter worth about $30,000. Future Financial Wealth Managment LLC acquired a new stake in Healthpeak Properties during the first quarter worth about $30,000. S.A. Mason LLC raised its position in Healthpeak Properties by 160.9% during the first quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust’s stock valued at $30,000 after acquiring an additional 925 shares in the last quarter. Finally, Covestor Ltd lifted its holdings in Healthpeak Properties by 173.8% in the fourth quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust’s stock valued at $37,000 after acquiring an additional 1,152 shares during the period. 93.57% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Healthpeak Properties
In other Healthpeak Properties news, Director Tommy G. Thompson acquired 5,777 shares of the business’s stock in a transaction on Wednesday, May 28th. The stock was bought at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the acquisition, the director owned 144,290 shares in the company, valued at approximately $2,491,888.30. The trade was a 4.17% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director John T. Thomas bought 4,200 shares of the firm’s stock in a transaction on Monday, April 28th. The stock was acquired at an average cost of $17.84 per share, for a total transaction of $74,928.00. Following the completion of the purchase, the director directly owned 813,566 shares in the company, valued at approximately $14,514,017.44. This represents a 0.52% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 29,764 shares of company stock valued at $521,909. Corporate insiders own 0.23% of the company’s stock.
Healthpeak Properties Stock Performance
Healthpeak Properties (NYSE:DOC – Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, meeting the consensus estimate of $0.46. The firm had revenue of $702.89 million during the quarter, compared to the consensus estimate of $690.76 million. Healthpeak Properties had a return on equity of 3.06% and a net margin of 9.99%. The firm’s revenue was up 15.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.45 EPS. As a group, equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.
Healthpeak Properties Dividend Announcement
The firm also recently announced a dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were given a $0.1017 dividend. This represents a dividend yield of 7.05%. The ex-dividend date of this dividend was Monday, May 19th. Healthpeak Properties’s dividend payout ratio (DPR) is 305.00%.
Wall Street Analyst Weigh In
Several research firms have commented on DOC. Wells Fargo & Company lowered their price objective on Healthpeak Properties from $22.00 to $20.00 and set an “equal weight” rating on the stock in a research report on Monday, June 2nd. Wedbush lowered their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating on the stock in a report on Monday, April 28th. Robert W. Baird cut their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating for the company in a report on Tuesday, April 29th. Argus reissued a “buy” rating and set a $25.00 target price on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Finally, Evercore ISI dropped their target price on Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating on the stock in a research report on Monday, April 28th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $23.27.
Check Out Our Latest Stock Analysis on DOC
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Recommended Stories
- Five stocks we like better than Healthpeak Properties
- Are Penny Stocks a Good Fit for Your Portfolio?
- Jefferies Raises Broadcom Price Target to $315: 19% Upside Ahead
- How to buy stock: A step-by-step guide for beginners
- Whiplash for Investors: AeroVironment’s Confusing Stock Signals
- What is a Microcap Stock? Everything You Need to Know
- The Ultimate Trump Bump: These Gov’t Backed Stocks Are Exploding
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC – Free Report).
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.